Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

WAY-605471

Copy Product Info
😃Good
Catalog No. T9822Cas No. 378223-81-5

WAY-605471 is a AHR antagonist with IC50 of 0.5 - 1 μM.

WAY-605471

WAY-605471

Copy Product Info
😃Good
Purity: 99.62%
Catalog No. T9822Cas No. 378223-81-5
WAY-605471 is a AHR antagonist with IC50 of 0.5 - 1 μM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$70-In Stock
5 mg$161-In Stock
10 mg$237-In Stock
25 mg$355-In Stock
50 mg$497-In Stock
100 mg$678-In Stock
1 mL x 10 mM (in DMSO)$157-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.62%
Appearance:Solid
Color:Orange
Contact us for more batch information

Resource Download

Product Introduction

WAY-605471 AI Summary
WAY-605471 exhibits a diverse range of bioactivities across various biological systems. Notably, it increases the expression of NF-kB in Human Neuronal Cells with an EC50 of 952.0 nM and activates STAT1 with an EC50 of 233.0 nM. In addition, it modulates miRNAs, particularly activating miR-21 with a potency of 369.0 nM, and activates the Rab9 Promoter with a potency of 562.3 nM. The compound enhances SMN2 Splice Variant Expression with a potency of 6309.6 nM and inhibits multiple viral activities including Hepatitis C Virus at 10000.0 nM and Foot and Mouth Disease Virus at 891.3 nM. It also shows antiviral potential against SARS-CoV-2 by demonstrating a 21.04% inhibition of 3CL-Pro protease activity at 20 µM and inhibiting cytotoxicity in VERO-6 cells. Furthermore, WAY-605471 inhibits various enzymes and transcriptional activities, such as ROR gamma with a potency of 158.5 nM, and demonstrates potential in inhibiting protein interactions and DNA repair mechanisms. The compound also inhibits Tau Fibril Formation and diverse cellular activities in Drosophila S3 cells, Leukemia models, and other human cell lines..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
WAY-605471 is a AHR antagonist with IC50 of 0.5 - 1 μM.
Chemical Properties
Molecular Weight309.4
FormulaC14H15NO3S2
Cas No.378223-81-5
SmilesN(C(=O)C1=C(C)C=CS1)C=2SC(C(OCC)=O)=C(C)C2
Relative Density.1.321 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 55 mg/mL (177.76 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.2321 mL16.1603 mL32.3206 mL161.6031 mL
5 mM0.6464 mL3.2321 mL6.4641 mL32.3206 mL
10 mM0.3232 mL1.6160 mL3.2321 mL16.1603 mL
20 mM0.1616 mL0.8080 mL1.6160 mL8.0802 mL
50 mM0.0646 mL0.3232 mL0.6464 mL3.2321 mL
100 mM0.0323 mL0.1616 mL0.3232 mL1.6160 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy WAY-605471 | purchase WAY-605471 | WAY-605471 cost | order WAY-605471 | WAY-605471 chemical structure | WAY-605471 formula | WAY-605471 molecular weight